Hyperfine, Inc. $HYPR Shares Purchased by Catalio Capital Management LP

Catalio Capital Management LP increased its holdings in shares of Hyperfine, Inc. (NASDAQ:HYPR) by 92.8% in the fourth quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 1,320,041 shares of the company’s stock after purchasing an additional 635,500 shares during the quarter. Catalio Capital Management LP owned 1.36% of Hyperfine worth $1,293,000 as of its most recent filing with the SEC.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Sanctuary Advisors LLC increased its position in Hyperfine by 130.9% during the 4th quarter. Sanctuary Advisors LLC now owns 39,938 shares of the company’s stock worth $39,000 after purchasing an additional 22,638 shares in the last quarter. Kathmere Capital Management LLC purchased a new position in Hyperfine in the 4th quarter worth approximately $51,000. Cerity Partners LLC purchased a new position in Hyperfine in the 4th quarter worth approximately $59,000. Tortoise Investment Management LLC purchased a new position in Hyperfine in the 3rd quarter worth approximately $65,000. Finally, Bridgeway Capital Management LLC boosted its holdings in Hyperfine by 50.2% in the 4th quarter. Bridgeway Capital Management LLC now owns 119,700 shares of the company’s stock worth $117,000 after acquiring an additional 40,000 shares during the period. Institutional investors and hedge funds own 15.03% of the company’s stock.

Hyperfine Stock Performance

Shares of HYPR opened at $1.39 on Thursday. The business’s 50 day moving average is $1.44 and its two-hundred day moving average is $1.22. Hyperfine, Inc. has a 52-week low of $0.66 and a 52-week high of $2.22. The firm has a market cap of $137.99 million, a price-to-earnings ratio of -3.39 and a beta of 1.38. The company has a quick ratio of 4.90, a current ratio of 5.52 and a debt-to-equity ratio of 0.38.

Hyperfine (NASDAQ:HYPR) last announced its earnings results on Tuesday, May 12th. The company reported ($0.09) earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of ($0.09). Hyperfine had a negative return on equity of 98.83% and a negative net margin of 226.88%.The company had revenue of $3.90 million for the quarter, compared to analyst estimates of $3.54 million. Analysts forecast that Hyperfine, Inc. will post -0.34 EPS for the current fiscal year.

Wall Street Analyst Weigh In

A number of equities analysts have weighed in on HYPR shares. Weiss Ratings restated a “sell (d-)” rating on shares of Hyperfine in a report on Tuesday, April 21st. BTIG Research started coverage on Hyperfine in a report on Wednesday, April 29th. They issued a “buy” rating and a $2.00 price target for the company. B. Riley Financial restated a “buy” rating on shares of Hyperfine in a report on Wednesday, May 13th. Lake Street Capital upped their price target on Hyperfine from $2.00 to $2.50 and gave the stock a “buy” rating in a report on Thursday, March 19th. Finally, Zacks Research upgraded Hyperfine to a “hold” rating in a report on Thursday, March 19th. Three research analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, the company has an average rating of “Hold” and an average target price of $1.78.

Insider Activity at Hyperfine

In related news, CFO Brett Hale sold 24,188 shares of the company’s stock in a transaction that occurred on Monday, March 23rd. The stock was sold at an average price of $1.21, for a total transaction of $29,267.48. Following the sale, the chief financial officer directly owned 275,812 shares of the company’s stock, valued at approximately $333,732.52. This represents a 8.06% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, COO Thomas Teisseyre sold 24,188 shares of the company’s stock in a transaction that occurred on Monday, March 23rd. The shares were sold at an average price of $1.21, for a total value of $29,267.48. Following the sale, the chief operating officer directly owned 354,648 shares in the company, valued at approximately $429,124.08. This represents a 6.38% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Over the last three months, insiders have sold 60,470 shares of company stock worth $78,490. Corporate insiders own 26.33% of the company’s stock.

Hyperfine Profile

Hyperfine, Inc (NASDAQ: HYPR) is a medical technology company focused on expanding access to advanced neuroimaging through its portable magnetic resonance imaging (MRI) system. The company’s flagship product, Swoop®, is designed to enable bedside MRI scanning in a wide range of clinical environments, including emergency departments, intensive care units and outpatient clinics. By leveraging a compact, high-performance permanent magnet and a custom-designed gradient system, Hyperfine aims to reduce the logistical and financial barriers associated with traditional, large-scale MRI installations.

The Swoop system features a lightweight, wheeled design that can be maneuvered directly to a patient’s bedside, allowing clinicians to conduct diagnostic imaging without the need to transport critically ill or immobile patients.